慢性丙型病毒性肝炎患者接受干扰素-α和利巴韦林治疗的眼内并发症
Intraocular complications of IFN-alpha and ribavirin therapy in patients with chronic viral hepatitis C.
作者信息
Sene Damien, Touitou Valerie, Bodaghi Bahram, Saadoun David, Perlemuter Gabriel, Cassoux Nathalie, Piette Jean-Charles, Hoang Phuc-Le, Cacoub Patrice
机构信息
Department of Internal Medicine, Hôpital Pitié-Salpêtrière, Paris, France.
出版信息
World J Gastroenterol. 2007 Jun 14;13(22):3137-40. doi: 10.3748/wjg.v13.i22.3137.
Abstract
We report a panel of severe inflammatory and vascular intraocular disorders occurring during interferon-alpha (IFN-alpha) treatment in eight hepatitis C virus (HCV)-infected patients. These events include three cases of Vogt-Koyanagi-Harada like (VKH) disease (an association of panuveitis, retinal detachment, ear and meningeal detachment and skin and hair changes), two cases of central retinal vein occlusion, one case of central retinal artery occlusion, one case of severe hypertensive retinopathy and one case of bilateral ischemic optic neuropathy with severe visual impairment. Rare as they are, such severe ophthalmological complications require a close follow-up of HCV-infected patients under IFN-alpha treatment with ophthalmological monitoring if any ocular manifestation occurs.
摘要
我们报告了8例丙型肝炎病毒（HCV）感染患者在接受α干扰素（IFN-α）治疗期间发生的一系列严重的炎症性和血管性眼内疾病。这些事件包括3例Vogt-小柳原田样（VKH）病（一种伴有全葡萄膜炎、视网膜脱离、耳部和脑膜病变以及皮肤和毛发改变的综合征）、2例视网膜中央静脉阻塞、1例视网膜中央动脉阻塞、1例严重高血压性视网膜病变以及1例伴有严重视力损害的双侧缺血性视神经病变。尽管这些严重的眼科并发症很罕见，但对于接受IFN-α治疗的HCV感染患者，如果出现任何眼部表现，都需要密切随访并进行眼科监测。
相似文献
1
Intraocular complications of IFN-alpha and ribavirin therapy in patients with chronic viral hepatitis C.
World J Gastroenterol. 2007 Jun 14;13(22):3137-40. doi: 10.3748/wjg.v13.i22.3137.
2
Vogt-Koyanagi-Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection.
J Infect. 2006 Feb;52(2):e59-61. doi: 10.1016/j.jinf.2005.05.005. Epub 2005 Jun 13.
3
Vogt-Koyanagi-Harada disease occurring during interferon-alpha and ribavirin therapy for chronic hepatitis C virus infection.
Int Ophthalmol. 2010 Oct;30(5):611-3. doi: 10.1007/s10792-010-9357-0. Epub 2010 Feb 23.
4
[Vogt-Koyanagi-Harada disease associated with interferon-alpha and ribavirin therapy for chronic hepatitis C infection].
J Fr Ophtalmol. 2010 Mar;33(3):185-8. doi: 10.1016/j.jfo.2010.01.009. Epub 2010 Feb 20.
5
Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C.
Korean J Hepatol. 2011 Mar;17(1):61-5. doi: 10.3350/kjhep.2011.17.1.61.
6
Induction of Vogt-Koyanagi-Harada Disease by Interferon-Alpha and Ribavirin Treatment in Patients with Hepatitis C: A Case Report and Review of the Literature.
Ocul Immunol Inflamm. 2019;27(2):229-234. doi: 10.1080/09273948.2017.1373827. Epub 2017 Oct 12.
7
[Bilateral non-arteritic ischemic optic neuropathy during treatment of viral hepatitis C with pegylated interferon and Ribavirin].
J Fr Ophtalmol. 2015 Jan;38(1):34-40. doi: 10.1016/j.jfo.2014.06.008. Epub 2014 Dec 18.
8
Anterior ischemic optic neuropathy complicating interferon alpha and ribavirin therapy in patients with chronic hepatitisC.
Gastroenterol Clin Biol. 2009 Feb;33(2):115-7. doi: 10.1016/j.gcb.2008.12.004. Epub 2009 Feb 6.
9
Vogt-Koyanagi-Harada disease associated with interferon alpha-2b/ribavirin combination therapy.
J Viral Hepat. 2003 Nov;10(6):467-70. doi: 10.1046/j.1365-2893.2003.00456.x.
10
Vogt-Koyanagi-Harada disease occurring during interferon alpha therapy for chronic hepatitis C.
J Gastroenterol. 2004 Nov;39(11):1106-9. doi: 10.1007/s00535-004-1452-4.
引用本文的文献
1
Ocular side effects of antirheumatic medications: a qualitative review.
BMJ Open Ophthalmol. 2020 Jan 7;5(1):e000331. doi: 10.1136/bmjophth-2019-000331. eCollection 2020.
2
Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature.
World J Clin Cases. 2019 May 6;7(9):1043-1052. doi: 10.12998/wjcc.v7.i9.1043.
3
Interferon-α-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations.
Graefes Arch Clin Exp Ophthalmol. 2019 Mar;257(3):447-452. doi: 10.1007/s00417-018-04209-7. Epub 2018 Dec 13.
4
RELATIONSHIP BETWEEN UVEITIS, DIFFERENT TYPES OF VIRAL HEPATITIS, AND LIVER CIRRHOSIS: A 12-Year Nationwide Population-Based Cohort Study.
Retina. 2016 Dec;36(12):2391-2398. doi: 10.1097/IAE.0000000000001103.
5
Ophthalmological side effects of interferon therapy of chronic hepatitis C.
Hepatobiliary Surg Nutr. 2016 Jun;5(3):209-16. doi: 10.21037/hbsn.2015.12.14.
6
KASL clinical practice guidelines: management of hepatitis C.
Clin Mol Hepatol. 2016 Mar;22(1):76-139. doi: 10.3350/cmh.2016.22.1.76. Epub 2016 Mar 28.
7
Thrombosis Associated with Viral Hepatitis.
J Clin Transl Hepatol. 2014 Dec;2(4):234-9. doi: 10.14218/JCTH.2014.00031. Epub 2014 Dec 15.
8
KASL clinical practice guidelines: management of hepatitis C.
Clin Mol Hepatol. 2014 Jun;20(2):89-136. doi: 10.3350/cmh.2014.20.2.89. Epub 2014 Jun 30.
9
Ophthalmologic complications of antiviral therapy in hepatitis C treatment.
World J Gastroenterol. 2013 Dec 7;19(45):8227-37. doi: 10.3748/wjg.v19.i45.8227.
10
Bilateral Ischemic Optic Neuropathy Developed under Interferon Therapy.
Case Rep Ophthalmol Med. 2012;2012:102739. doi: 10.1155/2012/102739. Epub 2012 Oct 18.
本文引用的文献
1
Vogt-Koyanagi-Harada disease in patients with chronic hepatitis C.
Am J Ophthalmol. 2005 Nov;140(5):949-52. doi: 10.1016/j.ajo.2005.06.020.
2
Vogt-Koyanagi-Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection.
J Infect. 2006 Feb;52(2):e59-61. doi: 10.1016/j.jinf.2005.05.005. Epub 2005 Jun 13.
3
[Diagnostic and therapeutic management of Vogt-Koyanagi-Harada syndrome].
J Fr Ophtalmol. 2005 Jan;28(1):9-16. doi: 10.1016/s0181-5512(05)81020-4.
4
Serious ophthalmic pathology compromising vision in HCV/HIV co-infected patients treated with peginterferon alpha-2b and ribavirin.
AIDS. 2004 Sep 3;18(13):1805-9. doi: 10.1097/00002030-200409030-00009.
5
Vogt-Koyanagi-Harada disease associated with interferon alpha-2b/ribavirin combination therapy.
J Viral Hepat. 2003 Nov;10(6):467-70. doi: 10.1046/j.1365-2893.2003.00456.x.
6
Hepatitis C virus infection in systemic lupus erythematosus: a case-control study.
J Rheumatol. 2003 Jul;30(7):1473-8.
7
Ocular manifestations of hepatitis C virus infection.
Curr Opin Ophthalmol. 2002 Dec;13(6):423-7. doi: 10.1097/00055735-200212000-00014.
8
Retinal vein thrombosis associated with chronic hepatitis C: a case series and review of the literature.
J Viral Hepat. 2000 Nov;7(6):466-70. doi: 10.1046/j.1365-2893.2000.00245.x.
9
Peginterferon alfa-2a in patients with chronic hepatitis C.
N Engl J Med. 2000 Dec 7;343(23):1666-72. doi: 10.1056/NEJM200012073432301.
10
Neurovisual impairment: a frequent complication of alpha-interferon treatment in chronic viral hepatitis.
Hepatology. 1998 May;27(5):1421-7. doi: 10.1002/hep.510270533.
Zotero 插件